As preventive efforts for metabolic disease are increasingly focusing on tackling obesity in childhood22, knowledge regarding the prevalence of MC4R LoF mutations and their impact on body composition and growth during the first decades of life will be increasingly important and relevant to future drug development. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.